Immutep

Michel Gréco

Immutep S.A. announced today the appointment of Michel Gréco to its Board of Directors. Mr. Gréco brings over 30 years of experience of the vaccine and pharmaceutical industry and presently sits on the Boards of several private and publicly-quoted companies, the International AIDS Vaccine Initiative (IAVI), the Aeras Global Tuberculosis Vaccines Foundation and the International Vaccine Institute (IVI). He is also the present Chair of WHO’s Initiative for Vaccine Research Advisory Committee.

Previously Michel Gréco was a member of the Supervisory Board of Aventis Pasteur, a world-leading vaccine manufacturer now Sanofi Pasteur, having been Deputy Chief Executive Officer or President and Chief Operating Officer for four years.

Please, click on ADOBE PDF logo to read the complete communique.

Published 09/2005 by admin@immutep.com